Alpha interferon improves survival in patients with metastatic renal carcinoma - Updated results of an MRC randomised controlled trial.

被引：0
|
作者：
Oliver, RTD [1 ]
机构：
[1] MRC, Clin Trials Unit, Canc Div, Cambridge CB2 2BW, England
来源：
BRITISH JOURNAL OF CANCER | 1999年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P161
引用
收藏
页码：69 / 69
页数：1
相关论文
共 50 条
  • [31] METASTATIC RENAL-CELL CARCINOMA - INTERFERON ALPHA-2 AND VINBLASTINE COMBINED THERAPY - RESULTS OF A SERIES OF 21 PATIENTS
    JACQMIN, D
    BERGERAT, JP
    DUFOUR, P
    PREVOT, G
    JURACHESCK, F
    BOLLACK, C
    OBERLING, F
    JOURNAL OF UROLOGY, 1987, 137 (04): : A329 - A329
  • [32] ALPHA-2-INTERFERON IN RENAL-CELL CARCINOMA - RESULTS IN 6 PATIENTS
    WEIDMANN, B
    HOFFMANN, W
    SEEBER, S
    ONKOLOGIE, 1990, 13 (03): : 217 - 220
  • [33] Long term survival benefit after adjuvant treatment of high risk cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised, multicentre trial.
    Stadler, R
    Luger, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 714S - 714S
  • [34] Nivolumab for metastatic renal cell carcinoma (mRCC): Results of a randomized, dose-ranging phase II trial.
    Motzer, Robert J.
    Rini, Brian I.
    McDermott, David F.
    Redman, Bruce G.
    Kuzel, Timothy
    Harrison, Michael Roger
    Vaishampayan, Ulka N.
    Drabkin, Harry A.
    George, Saby
    Logan, Theodore F.
    Margolin, Kim Allyson
    Plimack, Elizabeth R.
    Waxman, Ian
    Lambert, Alexandre
    Hammers, Hans J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] Ketoprofen plus interferon-α in naive patients with chronic hepatitis C:: Results of a randomized, controlled trial.
    Andreone, P
    Gramenzi, A
    Cursaro, C
    Felline, F
    Di Giammarino, L
    Biselli, M
    Romano, S
    Lorenzini, S
    Porzio, F
    Bernardi, M
    HEPATOLOGY, 2001, 34 (04) : 587A - 587A
  • [36] Antiviral Therapy Improves Postoperative Survival in Patients With Hepatocellular Carcinoma A Randomized Controlled Trial
    Huang, Gang
    Lau, Wan Yee
    Wang, Zhen-Guang
    Pan, Ze-Ya
    Yuan, Sheng-Xian
    Shen, Feng
    Zhou, Wei-Ping
    Wu, Meng-Chao
    ANNALS OF SURGERY, 2015, 261 (01) : 56 - 66
  • [37] Bevacizumab and erlotinib in the treatment of patients with metastatic renal carcinoma (RCC): Update of a phase II multicenter trial.
    Spigel, DR
    Hainsworth, JD
    Sosman, JA
    Raefsky, EL
    Meluch, AA
    Edwards, D
    Horowitz, P
    Thomas, K
    Yost, K
    Stagg, MP
    Greco, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 387S - 387S
  • [38] Preliminary results of a randomised placebo controlled trial of interferon alpha versus interferon alpha plus thymosin alpha-1 for treatment of chronic hepatitis B.
    Lim, SG
    Perumal, V
    Lee, YM
    Sutedja, DS
    Wai, DCT
    Lim, LL
    Liew, KVS
    Chia, SC
    Fock, KM
    Wee, A
    Suresh, S
    Machin, D
    HEPATOLOGY, 2000, 32 (04) : 583A - 583A
  • [39] Sunitinib as first-line treatment for metastatic renal cell carcinoma (MRCC): Updated results and analysis of prognostic factors from a phase III randomised trial
    Oudard, S.
    Motzer, R. J.
    Michaelson, M. D.
    Hutson, T. E.
    Tomczak, P.
    Bukowski, R. M.
    Rixie, O.
    Negrier, S.
    Kim, S. T.
    Chen, J.
    Figlin, R. A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 245 - 245
  • [40] Infliximab improves fatigue and pain in patients with ankylosing spondylitis: Results of a randomized, placebo-controlled trial.
    van der Heijde, D
    Han, CL
    Bala, M
    Williamson, P
    Han, J
    Braun, J
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S35 - S35
12345